knowledge -WSS

knowledge

author：focus 2025-09-27 10:04:28 - browse：2136

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medical records are filled with copy
Next article： FDA scientists endorse Pfizer/BioNTech Covid

WSS

How to ethically and practically extend health care to all

Report cites 'urgent' need to recruit more diverse clinical trial participants

Study gives hint on South Asians’ higher risk of cardiovascular disease

Resistance to opioid

Alnylam reports growth in sales of rare disease treatments

Juul documents reveal insider tactics on political lobbying

knowledge

knowledge

focus

New air purifier tech could be key to improving indoor air quality

Long Covid research funding gets a major boost from NIH

Heart attack and stroke risk calculators need revising

When waiting feels immoral: Empathy in the emergency department

The cancer drug shortage isn’t new — and neither are the solutions

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

The cancer drug shortage isn’t new — and neither are the solutions

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

leisure time

ACIP vaccine advisory panel sees its vacancies filled

Biotech startup Celsius cuts 75% of staff ahead of first trial start

How I helped Pfizer think through the ethics of Viagra

Congress must protect the remaining independent doctors

When waiting feels immoral: Empathy in the emergency department

Why Eli Lilly’s earnings didn’t quite live up to the hype

Wikipedia

focus

focus

hotspot